Rockwell Medical, Inc. (RMTI): Shareholders' Equity
$36.98M
As of 2025-12-31
$35.09M
As of 2026-06-30
+37.9%
3-year compound annual growth
+1.6%
5-year compound annual growth
-5.1%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $36.98M | +13.5% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $32.59M | +53.1% | 2026-03-26, Balance as of period end |
| 2023-12-31 | $21.29M | +50.9% | 2025-03-20, Balance as of period end |
| 2022-12-31 | $14.11M | +456.4% | 2024-03-21, Balance as of period end |
| 2021-12-31 | $2.54M | -92.6% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $34.17M | +68.2% | 2022-04-08, Balance as of period end |
| 2019-12-31 | $20.32M | -25.5% | 2021-03-31, Balance as of period end |
| 2018-12-31 | $27.28M | -17.1% | 2020-03-17, Balance as of period end |
| 2017-12-31 | $32.91M | -37.8% | 2019-03-18, Balance as of period end |
| 2016-12-31 | $52.96M | -15.0% | 2018-03-15, Balance as of period end |
| 2015-12-31 | $62.32M | -9.3% | 2018-03-15, Balance as of period end |
| 2014-12-31 | $68.70M | n/m | 2017-03-15, Balance as of period end |
| 2013-12-31 | $595.5K | n/m | 2016-02-29, Balance as of period end |
| 2012-12-31 | -$9.96M | n/m | 2015-03-03, Balance as of period end |
| 2011-12-31 | $18.24M | -40.3% | 2014-03-07, Balance as of period end |
| 2010-12-31 | $30.54M | +4.1% | 2013-03-18, Balance as of period end |
| 2009-12-31 | $29.32M | n/a | 2012-03-05, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Rockwell Medical, Inc. (RMTI) | 2025-12-31 | $36.98M | +13.5% |
| Viridian Therapeutics, Inc. (VRDN) | 2025-12-31 | $722.17M | +7.5% |
| Kura Oncology, Inc. (KURA) | 2025-12-31 | $174.13M | -57.9% |
| Spero Therapeutics, Inc. (SPRO) | 2025-12-31 | $59.02M | +28.0% |
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | $206.75M | +519.8% |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | $609.98M | -23.1% |
| Enanta Pharmaceuticals Inc (ENTA) | 2025-09-30 | $64.72M | -49.8% |
| AbCellera Biologics Inc. (ABCL) | 2025-12-31 | $966.90M | -8.4% |
| Fortress Biotech, Inc. (FBIO) | 2025-12-31 | $49.87M | +119.3% |
Compare RMTI, VRDN, KURA, SPRO side by side · Screen every company in Pharmaceutical Preparations ↗